#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	12142	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2573	580.0	0	.	n	.	0	C1450T	SNP	1450	1450	C	2048	2048	T	826	T,G,A	822,2,2	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	12142	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2573	580.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1782	1782	C	757	C,T,A	755,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	20398	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3988	637.5	0	.	n	.	0	G1337A	SNP	1337	1337	G	1900	1900	A	828	A	828	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	20398	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3988	637.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2534	2534	C	653	C,G	652,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	20398	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3988	637.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2608	2608	A	609	A,C	606,3	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	20398	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3988	637.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	3160	3160	C	704	C,T,A	702,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1344	folP	852	852	93.78	folP.l15.c4.ctg.1	1956	85.7	0	.	p	.	0	G5V	NONSYN	13	15	GGT	572	574	GTT	92;93;95	G;T,C;T	92;92,1;95	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1344	folP	852	852	93.78	folP.l15.c4.ctg.1	1956	85.7	0	.	p	.	0	E12K	NONSYN	34	36	GAA	593	595	AAA	111;112;112	A;A;A	111;112;112	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1344	folP	852	852	93.78	folP.l15.c4.ctg.1	1956	85.7	0	.	p	.	0	F31L	NONSYN	91	93	TTT	650	652	TTG	120;121;120	T;T;G	120;121;120	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1344	folP	852	852	93.78	folP.l15.c4.ctg.1	1956	85.7	0	.	p	.	0	K42Q	NONSYN	124	126	AAA	683	685	CAA	152;152;152	C,A;A;A,C	151,1;152;151,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1344	folP	852	852	93.78	folP.l15.c4.ctg.1	1956	85.7	0	.	p	.	0	S75P	NONSYN	223	225	TCC	782	784	CCT	168;169;170	C;C;T	168;169;170	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1344	folP	852	852	93.78	folP.l15.c4.ctg.1	1956	85.7	0	.	p	.	0	V87A	NONSYN	259	261	GTA	818	820	GCA	137;133;132	G;C,T;A	137;132,1;132	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1344	folP	852	852	93.78	folP.l15.c4.ctg.1	1956	85.7	0	.	p	.	0	V130L	NONSYN	388	390	GTC	947	949	CTC	168;168;171	C,G;T,G;C	167,1;167,1;171	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1344	folP	852	852	93.78	folP.l15.c4.ctg.1	1956	85.7	0	.	p	.	0	R135C	NONSYN	403	405	CGC	962	964	TGT	181;179;180	T,C;G;T,C,G	180,1;179;178,1,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1344	folP	852	852	93.78	folP.l15.c4.ctg.1	1956	85.7	0	.	p	.	0	T137A	NONSYN	409	411	ACG	968	970	GCG	182;182;182	G,T;C;G,T	181,1;182;181,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1344	folP	852	852	93.78	folP.l15.c4.ctg.1	1956	85.7	0	.	p	.	0	E151K	NONSYN	451	453	GAA	1010	1012	AAG	183;180;179	A,T;A,C;G,A	182,1;179,1;178,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1344	folP	852	852	93.78	folP.l15.c4.ctg.1	1956	85.7	0	.	p	.	0	T152N	NONSYN	454	456	ACC	1013	1015	AAT	179;183;186	A,C;A,C;T,C,A	177,2;182,1;184,1,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1344	folP	852	852	93.78	folP.l15.c4.ctg.1	1956	85.7	0	.	p	.	0	F218L	NONSYN	652	654	TTT	1211	1213	TTG	109;107;106	T,G;T;G	108,1;107;106	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1344	folP	852	852	93.78	folP.l15.c4.ctg.1	1956	85.7	1	SNP	p	R228S	1	R228S	NONSYN	682	684	CGT	1241	1243	AGC	115;114;114	A;G;C	115;114;114	folP.Neisseria_meningitidis_M01_240149_v1_00504:1:1:R228S:folP.228S:Resistance to sulphonamides	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1344	folP	852	852	93.78	folP.l15.c4.ctg.1	1956	85.7	0	.	p	.	0	V251L	NONSYN	751	753	GTG	1310	1312	CTG	96;97;95	C;T;G	96;97;95	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1344	folP	852	852	93.78	folP.l15.c4.ctg.1	1956	85.7	0	.	p	.	0	A253S	NONSYN	757	759	GCT	1316	1318	TCC	90;90;92	T;C;C	90;90;92	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1344	folP	852	852	93.78	folP.l15.c4.ctg.1	1956	85.7	0	.	p	.	0	A258V	NONSYN	772	774	GCG	1331	1333	GTG	106;108;108	G;T;G	106;108;108	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1344	folP	852	852	93.78	folP.l15.c4.ctg.1	1956	85.7	0	.	p	.	0	V275A	NONSYN	823	825	GTG	1382	1384	GCG	144;142;144	G;C;G	144;142;144	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4442	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3958	139.8	1	SNP	p	S91F	0	.	.	271	273	TCC	794	796	TCC	189;187;188	T;C;C	189;187;188	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4442	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3958	139.8	1	SNP	p	D95N	0	.	.	283	285	GAC	806	808	GAC	190;188;187	G;A;C	190;188;187	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4442	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3958	139.8	1	SNP	p	D95G	0	.	.	283	285	GAC	806	808	GAC	190;188;187	G;A;C	190;188;187	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_M_01390	mtrR.WHO_M_01390	1	1	531	1500	mtrR	633	633	99.68	mtrR.l15.c4.ctg.1	1825	102.6	0	.	p	.	0	Q133trunc	TRUNC	397	397	C	977	977	T	176	T	176	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	854	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1488	71.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	3860	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3434	140.1	0	.	p	.	0	V384I	NONSYN	1150	1152	GTC	1711	1713	ATC	183;185;190	A,T;T,A;C	182,1;184,1;190	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	3860	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3434	140.1	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1864	1866	GCA	172;174;174	G,T;C;A	171,1;174;174	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	3860	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3434	140.1	1	SNP	p	D86N	0	.	.	256	258	GAC	817	819	GAC	184;186;188	G;A;C	184;186;188	parC.WHO_G_00206c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	3860	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3434	140.1	1	SNP	p	S87I	0	.	.	259	261	AGT	820	822	AGT	190;187;186	A;G;T	190;187;186	parC.WHO_G_00206c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	3860	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3434	140.1	1	SNP	p	S87W	0	.	.	259	261	AGT	820	822	AGT	190;187;186	A;G;T	190;187;186	parC.WHO_G_00206c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	3860	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3434	140.1	1	SNP	p	S87R	0	.	.	259	261	AGT	820	822	AGT	190;187;186	A;G;T	190;187;186	parC.WHO_G_00206c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	3860	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3434	140.1	1	SNP	p	S88P	0	.	.	262	264	TCC	823	825	TCC	186;187;187	T;C;C	186;187;187	parC.WHO_G_00206c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3428	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2970	143.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1737	1739	GGC	178;175;177	G;G;C	178;175;177	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.14.001	penA.14.001	1	1	27	3314	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2817	146.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1470	1472	GCA	202;204;206	G;C,T;A	202;203,1;206	penA.14.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3314	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2817	146.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1473	1475	ATC	206;207;204	A;T;C,T	206;207;203,1	penA.14.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3314	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2817	146.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1485	1487	GTG	206;208;206	G;T;G,T	206;208;205,1	penA.14.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3314	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2817	146.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1485	1487	GTG	206;208;206	G;T;G,T	206;208;205,1	penA.14.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3314	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2817	146.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1989	1991	ACC	199;195;196	A;C,G;C	199;194,1;196	penA.14.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3314	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2817	146.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2043	2045	GCG	190;190;194	G;C;G	190;190;194	penA.14.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3314	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2817	146.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2043	2045	GCG	190;190;194	G;C;G	190;190;194	penA.14.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3314	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2817	146.5	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2166	2168	GGT	187;188;186	G;G,T;T	187;187,1;186	penA.14.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3314	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2817	146.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2175	2177	GGC	176;177;177	G;G;C	176;177;177	penA.14.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3314	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2817	146.5	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2193	2195	CCG	182;181;180	C,G;C;G,C	181,1;181;179,1	penA.14.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	4472	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3618	154.3	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1910	1912	CTG	207;210;210	C;T;G	207;210;210	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1888	porA	1146	1146	99.74	porA.l15.c4.ctg.1	2370	99.5	0	.	p	.	0	S22G	NONSYN	64	66	AGC	674	676	GGC	130;136;134	G,T;G;C	129,1;136;134	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1888	porA	1146	1146	99.74	porA.l15.c4.ctg.1	2370	99.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	856	856	C	148	C	148	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2226	porB1b	1047	1047	96.95	porB1b.l15.c17.ctg.1	1656	166.6	0	.	p	.	0	G38E	NONSYN	112	114	GGA	552	554	GAA	201;199;201	G;A,C;A	201;198,1;201	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2226	porB1b	1047	1047	96.95	porB1b.l15.c17.ctg.1	1656	166.6	0	.	p	.	0	S46G	NONSYN	136	138	AGC	576	578	GGC	199;201;203	G;G;C	199;201;203	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2226	porB1b	1047	1047	96.95	porB1b.l15.c17.ctg.1	1656	166.6	0	.	p	.	0	E48G	NONSYN	142	144	GAA	582	584	GGA	196;199;199	G;G;A,T	196;199;198,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2226	porB1b	1047	1047	96.95	porB1b.l15.c17.ctg.1	1656	166.6	0	.	p	.	0	T87A	NONSYN	259	261	ACT	699	701	GCT	165;166;164	G,C;C;T	164,1;166;164	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2226	porB1b	1047	1047	96.95	porB1b.l15.c17.ctg.1	1656	166.6	0	.	p	.	0	T89S	NONSYN	265	267	ACC	705	707	AGC	160;162;162	A;G;C	160;162;162	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2226	porB1b	1047	1047	96.95	porB1b.l15.c17.ctg.1	1656	166.6	0	.	p	.	0	.	MULTIPLE	358	359	AA	797	798	CG	174;178	C;G	174;178	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2226	porB1b	1047	1047	96.95	porB1b.l15.c17.ctg.1	1656	166.6	0	.	p	.	0	.	MULTIPLE	361	362	GA	800	802	CAG	179;180;181	C;A,G;G,C	179;179,1;180,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2226	porB1b	1047	1047	96.95	porB1b.l15.c17.ctg.1	1656	166.6	0	.	p	.	0	N122K	NONSYN	364	366	AAC	804	806	AAA	181;184;185	A,C;A;A,C	180,1;184;184,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2226	porB1b	1047	1047	96.95	porB1b.l15.c17.ctg.1	1656	166.6	0	.	p	.	0	K143E	NONSYN	427	429	AAA	867	869	GAA	207;205;203	G,T;A;A	206,1;205;203	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2226	porB1b	1047	1047	96.95	porB1b.l15.c17.ctg.1	1656	166.6	0	.	p	.	0	V151A	NONSYN	451	453	GTA	891	893	GCA	202;200;202	G;C;A	202;200;202	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2226	porB1b	1047	1047	96.95	porB1b.l15.c17.ctg.1	1656	166.6	0	.	p	.	0	A215T	NONSYN	643	645	GCT	1083	1085	ACT	179;179;179	A;C,A;T	179;178,1;179	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2226	porB1b	1047	1047	96.95	porB1b.l15.c17.ctg.1	1656	166.6	0	.	p	.	0	I218M	NONSYN	652	654	ATA	1092	1094	ATG	174;171;170	A;T;G	174;171;170	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2226	porB1b	1047	1047	96.95	porB1b.l15.c17.ctg.1	1656	166.6	0	.	p	.	0	T256A	NONSYN	766	768	ACA	1206	1208	GCA	153;152;152	G,T;C;A	152,1;152;152	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2226	porB1b	1047	1047	96.95	porB1b.l15.c17.ctg.1	1656	166.6	0	.	p	.	0	W257T	NONSYN	769	771	TGG	1209	1211	ACG	153;155;157	A;C;G,T	153;155;155,2	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2226	porB1b	1047	1047	96.95	porB1b.l15.c17.ctg.1	1656	166.6	0	.	p	.	0	S258G	NONSYN	772	774	AGT	1212	1214	GGG	159;161;163	G,T;G,T;G	158,1;160,1;163	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2226	porB1b	1047	1047	96.95	porB1b.l15.c17.ctg.1	1656	166.6	0	.	p	.	0	A259V	NONSYN	775	777	GCT	1215	1217	GTT	164;165;169	G;T,C;T,G,A	164;164,1;167,1,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2226	porB1b	1047	1047	96.95	porB1b.l15.c17.ctg.1	1656	166.6	0	.	p	.	0	L279V	NONSYN	835	837	TTA	1275	1277	GTA	191;189;192	G,T;T;A	190,1;189;192	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2226	porB1b	1047	1047	96.95	porB1b.l15.c17.ctg.1	1656	166.6	0	.	p	.	0	S292T	NONSYN	874	876	TCT	1314	1316	ACT	224;226;227	A,T;C;T,C	223,1;226;226,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2226	porB1b	1047	1047	96.95	porB1b.l15.c17.ctg.1	1656	166.6	0	.	p	.	0	H294D	NONSYN	880	882	CAT	1320	1322	GAT	235;236;235	G;A,C;T	235;235,1;235	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2226	porB1b	1047	1047	96.95	porB1b.l15.c17.ctg.1	1656	166.6	0	.	p	.	0	Y298H	NONSYN	892	894	TAC	1332	1334	CAC	236;235;236	C;A,G;C	236;233,2;236	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2226	porB1b	1047	1047	96.95	porB1b.l15.c17.ctg.1	1656	166.6	0	.	p	.	0	D333N	NONSYN	997	999	GAC	1437	1439	AAC	173;175;176	A;A;C	173;174;176	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2226	porB1b	1047	1047	96.95	porB1b.l15.c17.ctg.1	1656	166.6	1	SNP	p	G120K	1	.	.	358	360	AAG	797	799	CGG	174;178;176	C;G;G	174;178;176	porB1b.WHO_L_01891c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2226	porB1b	1047	1047	96.95	porB1b.l15.c17.ctg.1	1656	166.6	1	SNP	p	A121D	1	.	.	361	363	GAC	800	803	CGC	179;181;181	C;G,C;C	179;180,1;181	porB1b.WHO_L_01891c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2226	porB1b	1047	1047	96.95	porB1b.l15.c17.ctg.1	1656	166.6	1	SNP	p	D121N	0	.	.	361	363	GAC	800	803	CGC	179;181;181	C;G,C;C	179;180,1;181	porB1b.WHO_L_01891c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	8280	rpoB	4179	4179	99.95	rpoB.l15.c4.ctg.1	5419	190.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1174	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1469	99.5	1	SNP	p	V57M	1	.	.	169	171	ATG	789	791	ATG	211;211;210	A;T;G	211;211;210	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
